Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: Advancing Circulating Tumor Cells as Liquid Biopsies to Efficiently Target Metastatic Breast Cancer

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351(8):781–91.

    Article  CAS  Google Scholar 

  2. Bidard FC, Jacot W, Kiavue N, Dureau S, Kadi A, Brain E, et al. Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical Trial. JAMA Oncol. 2021;7(1):34–41.

    Article  Google Scholar 

  3. Ring A, Campo D, Porras TB, Kaur P, Forte VA, Tripathy D, et al. Circulating tumor cell transcriptomics as biopsy-surrogates in metastatic breast cancer. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-11135-2

    Article  PubMed  Google Scholar 

  4. Siegel MB, He X, Hoadley KA, Hoyle A, Pearce JB, Garrett AL, et al. Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer. J Clin Invest. 2018;128(4):1371–83.

    Article  Google Scholar 

  5. Gkountela S, Castro-Giner F, Szczerba BM, Vetter M, Landin J, Scherrer R, et al. Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding. Cell. 2019;176(1–2):98–112.

    Article  CAS  Google Scholar 

  6. Garralda E, Dienstmann R, Piris-Giménez A, et al. New clinical trial designs in the era of precision medicine. Mol Oncol. 2019;13(3):549–57.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Alexander Ring MD, PhD

    Present address: Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland

  2. Julie E. Lang MD

    Present address: Cleveland Clinic Breast Cancer Program, Division of Breast Services, Department of General Surgery, Cleveland, OH, USA

Authors and Affiliations

  1. Division of Surgical Oncology, Department of Surgery and University of Southern California Norris Cancer Center, University of Southern California, Los Angeles, CA, USA

    Alexander Ring MD, PhD & Julie E. Lang MD

Authors
  1. Alexander Ring MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Julie E. Lang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julie E. Lang MD.

Ethics declarations

Disclosure

Alexander Ring and Julie E. Lang declare no competing interest for the presented study. Although ANGLE plc provided research funds to the author’s institution, the authors have no relevant financial disclosures. The study sponsor did not influence data acquisition and analysis or the decision to publish.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ring, A., Lang, J.E. ASO Author Reflections: Advancing Circulating Tumor Cells as Liquid Biopsies to Efficiently Target Metastatic Breast Cancer. Ann Surg Oncol 29, 2895–2896 (2022). https://doi.org/10.1245/s10434-021-11139-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-11139-y

Search

Navigation